Metraipolis › archive › dc_d71858ef92e3
From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery — Europe PMC PMID:42212863
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42212863
- DOI
- 10.2196/101366
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-09T06:58:27.164Z
- SHA-256 of the archived text
b6214a9cf484c793569c16bbf4b7a120b161eb35b21bfca9b6a93769d0f799d2- Stable URL of this page
https://metraipolis.com/documento/dc_d71858ef92e3
How to cite
From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery — Europe PMC PMID:42212863 — Europe PMC (en), https://europepmc.org/article/MED/42212863 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d71858ef92e3 (Metraipolis archive dc_d71858ef92e3, sha256 b6214a9cf484c793569c16bbf4b7a120b161eb35b21bfca9b6a93769d0f799d2)
BibTeX
@misc{dcd71858ef92e3,
title = {From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery — Europe PMC PMID:42212863},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42212863},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d71858ef92e3; sha256 b6214a9cf484c793569c16bbf4b7a120b161eb35b21bfca9b6a93769d0f799d2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42212863. Agents can read the archived copy with the MCP tool read_document.